Mohs Center of Excellence for Surgery Invites Innovative Partnerships While Lowering Healthcare Costs for Employers

Mohs Center of Excellence in Surgery

Skin cancer is no small component of overall cancer costs and should not be excluded from the top most expensive conditions to treat.

CARY, NC, USA, March 25, 2022 / — Rather than focusing on the big picture of reducing costs, some companies are designing perks that specifically target certain conditions.

Cancer is one of the costliest conditions to treat, accounting for approximately 20% of a company’s healthcare expenditure.

The number of Americans who have had skin cancer at some point in the last three decades is estimated to be greater than the number of all other cancers combined, and skin cancer incidence rates have continued to increase.

Skin cancer is no small component of overall cancer costs and should not be excluded from the top most expensive conditions to treat. Each year in the United States, nearly 5 million people are treated for all skin cancers combined, with an estimated annual cost of $8.1 billion.
Skin cancer also has significant costs beyond those associated with treatment. The annual costs associated with days lost from work and days of restricted activity are estimated at $76.8 million for non-melanoma skin cancer and $29.4 million for melanoma.

Companies want to get patients to the right place to receive treatment based on the type of cancer they have.
High-level cancer treatment centers are designated as Centers of Excellence, and companies can contract services with them directly or through their insurer.

Currently, 40% of large companies use centers of excellence for cancer care, up 10% over the past two years, according to the National Business Group on Health (NGBH), a nonpartisan research group for large employers.

Employers across the country have discovered improved performance in their workforce by focusing on providing quality health care that is accessible and at predictable prices. The Center of Excellence’s popularity has grown due to its demonstrated ability to deliver better patient outcomes with greater efficiency at lower and more reasonable costs.

Trends identified by industry watchers have revealed a significant increase in the percentage of employers reviewing COEs as part of a health plan. The idea is for companies to encourage their workers to seek care from high-quality providers.

Variation in quality and cost is pervasive and plagues America’s health care delivery system. Centers of Excellence (COE) is a strategy for directing employees to healthcare providers who practice efficiently, with high quality, at reasonable and predictable prices.

Recognizing the need for a nationwide center of excellence in Mohs micrographic surgery, Surgical Review Corporation, SRC, a nonprofit patient safety organization that accredits top surgical institutions and healthcare professionals, has granted accreditation to the Cary Skin Center as a Mohs Micrographic Surgery Center of Excellence. . He is the first in the United States to obtain this recognition.

Founded in 2003, SRC is a non-profit patient safety organization that develops and administers the best accreditation programs for healthcare professionals, surgeons, hospitals and independent ambulatory care facilities worldwide.

These programs improve the safety and quality of patient care and reduce the overall costs associated with successful treatment. Data provided by program participants is used to determine which treatments work best. This information enables clinicians, patients, payers and policy makers to make informed decisions that improve healthcare delivery.

Mohs micrographic surgery continues to be the most advanced and effective treatment procedure available for skin cancer. The goal of the procedure is to completely remove the skin cancer while minimizing the removal of uninvolved healthy tissue. It is performed under local anesthesia on an outpatient basis.

The advantages of Mohs surgery are the highest cure rate (97-99%), full margin assessed, fewer recurrences, leaves the smallest surgical defect possible, preserves the maximum amount of tissue, increases the chances of ‘a good aesthetic result, the most cost-effective treatment of certain tumors and is done on an outpatient basis, with local anesthesia, pathology included.

Mohs surgery is performed by a specially trained dermatologist (who serves as a surgeon, pathologist, and reconstructive surgeon) who has completed one to two years of certified surgical training. In October 2018, the American Board of Medical Specialties approved the American Board of Dermatology’s request to create the Micrographic Dermatologic Surgery (MDS) subspecialty. The first national administration of the exam was held in October 2021. Now, employers can also search for board certification in MDS.

COEs are known to be the best at what they do, whether it’s heart care, joint replacements, cancer care, or some other medical practice. Offering the full continuum of care for diseases such as cancer and diabetes, COEs are committed to providing treatment at lower cost compared to less specialized facilities.

EOCs traditionally covered expensive procedures for individual and complex patients. For these conditions, like skin cancer surgery with Mohs micrographic surgery, patients are more willing to travel to get high quality results. Time-limited procedures are more easily reimbursed through bundled payments, which are built into many COE contracts to ensure appropriate coordination of care in the community and increase cost predictability.

An employer-sponsored Center of Excellence benefit typically has a $0 member cost to travel to the designated center for treatment, including surgery.

Cary Skin Center invites innovative partnerships focused on reducing employer healthcare costs.

Parker Eales
write to us here